I received some information about a new effort in using gene therapy for treating choroideremia (and other ocular diseases), started by a group in Canada, The Alberta Ocular Gene Therapy Team, at the University of Alberta, and along with the news about the spin-out of Spark Therapeutics from the Children’s Hospital of Philadelphia (CHOP), decided it was time to update my gene therapy tables.

The updated tables are now online, and can be accessed via this link to my blog ^[1].
The three tables list all of the companies/institutions involved, the applications being researched, and the status of the clinical trials underway. The latter include live links to the individual clinical trials on clinicaltrials.gov.